Tarlatamab–Durvalumab Maintenance for Extensive-Stage Small-Cell Lung Cancer
New England Journal of Medicine · 24.10.2026
DOI: 10.1056/nejmoa2609482 ↗Kurz gefasst
Fachartikel in der Zeitschrift New England Journal of Medicine, online erschienen am 24.10.2026. Verfasst von Maurice Pérol und 23 weiteren Autor:innen. Beteiligte Einrichtung: Léon Bérard Cancer Center, Lyon, France. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 14 Literaturangaben. Gefördert von: Amgen, AstraZeneca.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Autor:innen und Institutionen
- Léon Bérard Cancer Center, Lyon, France.
- National Cancer Center Hospital, Tokyo.
- Samsung Medical Center, Seoul, South Korea.
- University of Texas M.D. Anderson Cancer Center, Houston.
- West German Cancer Center, University Hospital Essen, Essen, Germany.
- Jilin Cancer Hospital, Changchun, China.
ORCID-Profile: Ahmet Sezer, Oscar Juan-Vidal, Gustavo Schvartsman
Förderung
- Amgen
- AstraZeneca
Zitieren
APA
Pérol, M., Yoshida, T., Ahn, M. J., Gay, C. M., Schuler, M., Liu, H., Sezer, A., Bilici, A., Korantzis, I., Lim, S. M., Otsubo, K., Juan-Vidal, O., Chen, Y., Schvartsman, G., Wang, H., Dingemans, A. C., Clarke, J. M., Desai, A., Marigil, M., …, & DeLLphi-305 Investigators (2026). Tarlatamab–Durvalumab Maintenance for Extensive-Stage Small-Cell Lung Cancer. New England Journal of Medicine. https://doi.org/10.1056/nejmoa2609482
Vancouver
Pérol M, Yoshida T, Ahn MJ, Gay CM, Schuler M, Liu H, et al. Tarlatamab–Durvalumab Maintenance for Extensive-Stage Small-Cell Lung Cancer. New England Journal of Medicine. 2026. doi:10.1056/nejmoa2609482
BibTeX
@article{Prol2026,
author = {Pérol, Maurice and Yoshida, Tatsuya and Ahn, Myung-Ju and Gay, Carl M and Schuler, Martin and Liu, Haifeng and Sezer, Ahmet and Bilici, Ahmet and Korantzis, Ippokratis and Lim, Sun Min and Otsubo, Kohei and Juan-Vidal, Oscar and Chen, Yuanbin and Schvartsman, Gustavo and Wang, Haiyong and Dingemans, Anne-Marie C and Clarke, Jeffrey M and Desai, Aakash and Marigil, Miguel and Chen, Yuqi and Abidi, Bazle and Wang, Jessie and Sands, Jacob and DeLLphi-305 Investigators, DeLLphi-305 Investigators},
title = {Tarlatamab–Durvalumab Maintenance for Extensive-Stage Small-Cell Lung Cancer},
journal = {New England Journal of Medicine},
year = {2026},
doi = {10.1056/nejmoa2609482}
}
EUVIMED